Related Experiment Video
Updated: Jul 19, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
[Paclitaxel induces apoptosis of acute leukemia cells in S phase]
Peng Zhang1, De-Ding Tao, Yong-Dong Feng
1Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Techology, Wuhan, Hubei, 430030, P. R. China.
Background & Objective:
Cell cycle specificity, an important feature of anticancer drugs, is commonly used in the design of combined chemotherapy. Paclitaxel is widely accepted as an G2/M phase-specific agent. However, cumulative evidences revealed that the cell cycle specificity of anticancer drugs in vitro is not always consistent as in vivo. This study was to observe the effect of paclitaxel on the cell cycle specificity in different cell models.
Methods:
Effects of paclitaxel on cell apoptosis of human lymphocyte leukemia cell line Molt-4 and 17 clinical specimens of acute leukemia were investigated using flow cytometry.
Results:
Paclitaxel induced G2/M phase-specific apoptosis in exponentially growing Molt-4 cells, G0/G1 phase-specific apoptosis in high-density cultured Molt-4 cells, and S phase-specific apoptosis in acute leukemia specimens.
Conclusions:
Paclitaxel exhibits different cell-cycle specificity in different models. Different from other studies, paclitaxel induces S phase-specific apoptosis in clinical leukemia specimens. This difference is most likely related to the growing status of the target cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
Cellular Injury V: Apoptosis and Autophagy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway